|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|
| Cash flows from operating activities: | |
| Net loss | |
| Depreciation and amortization | |
| Remeasurement of financial instruments | |
| Share-based compensation | |
| Non-cash interest expense | |
| Other financial expense (income), net | |
| Changes in fair value of commitment to shareholder | |
| Amortization of debt discount | |
| Inventory | |
| Accounts receivable, net | |
| Other current assets | |
| Other assets | |
| Trade payables | |
| Other accounts payable | |
| Convertible loans | |
| Accrued severance pay | |
| Net cash used in operating activities | |
| Purchase of property and equipment | |
| Net cash used in investing activities | |
| Proceeds from issuance of convertible loans | |
| Repayment of convertible loans | |
| Proceeds from redeemable crossover preferred shares | |
| Proceeds from bridge loans and warrants | |
| Net cash provided by financing activities | |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |
| (Decrease) in cash and cash equivalents, and restricted cash | |
| Cash, cash equivalents and restricted cash at the beginning of the year | |
| Cash, cash equivalents and restricted cash at the end of the year | |
| Supplemental disclosure of cash flow information: | |
| Cash paid for interest | |
| Noncash investing and financing activities | |
| Cashless exercise of stock options | |
| Issuance of SAFE liability | |
| Settlement of commitment to shareholder |
Loading...
